Cargando…
IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia
Tyrosine kinase inhibitor therapy has dramatically changed the outcome of chronic myeloid leukemia (CML) patients. However, the treatment is not considered to be curative and may present deleterious side effects, such that additional therapy options are warranted. Here, we discuss the beneficial imm...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063137/ https://www.ncbi.nlm.nih.gov/pubmed/25050224 http://dx.doi.org/10.4161/onci.28781 |